Chicago, Illinois 60614


The hypothesis of this study is that children with severe primary immunodeficiencies will benefit from early stem cell transplantation utilizing a reduced intensity conditioning regimen. This regimen is associated with a low risk of complications and will lead to correction of the underlying immunological defects.


Inclusion Criteria: - Must show one of the following diseases: - SCIDS - Hyper-IgM - Wiskott-Aldrich Syndrome - Chediak-Higashi and Griscelli Syndromes - X-Linked Lymphoproliferative Diseases - IPEX Syndrome - NEMO Syndrome - other severe immunodeficiency diseases not stated above at the discretion of the Principal Investigator - Informed Consent - Adequate Renal Function - Adequate Liver Function - Adequate Cardiac Function - Adequate Pulmonary Function - Adequate Performance Statue - Adequate Venous Access Exclusion Criteria: - Patient/Family has not signed informed consent - Patient does not have a clear diagnosis of a severe immunodeficiency disease - A suitable donor for the patient cannot be found - Patient is HIV positive - Patient has active Hepatitis B - Patient is pregnant - Patient is considered unsuitable for transplant at the discretion of the Principal Investigators or the medical director



Primary Contact:

Principal Investigator
Morris Kletzel, MD
Children's Memorial Hospital

Morris Kletzel, MD
Phone: 773-880-4562

Backup Contact:

Colleen E Schaefer, BS
Phone: 773-880-3459

Location Contact:

Chicago, Illinois 60614
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source:

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.